Patent · US Active

Compounds and compositions for inhibition of FASN

US10995078B2 · kind B2 · utility

0Cited by

59References

2Claims

0Family size

Assignee

FORMA Therapeutics, Inc. · US

Inventors

Kenneth W. Bair · Chapel Hill, US
David R. Lancia, Jr. · Boston, US
Hongbin Li · Newtown, US
James Loch · Watertown, US
Wei Lu · Newton, US
Matthew W. Martin · Arlington, US
David S. Millan · Watertown, US
Shawn Schiller · Haverhill, US
Mark J. Tebbe · Hamburg, DE

Key dates

Filing date	May 20, 2020
Grant date	May 4, 2021
Priority date	—
Expiry date	May 20, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to compounds and composition for inhibition of FASN, their synthesis, applications, and antidotes. An illustrative compound of the invention is shown below:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.